Jared A Sewell

2 Patents

• US125709552026

  Monoclonal Cell Lines Expressing an Exogenous Substance and Uses Thereof

  SIGILON THERAPEUTICS, Inc.

  0 cites
• US121617602024

  Implantable Particles and Related Methods

  SIGILON THERAPEUTICS, Inc.

  0 cites